According to a commentary, these data will help to inform clinicians of the risk of intracranial haemorrhage, but it does not that think that the key question of whether the risk outweighs the benefit of oral anticoagulation in preventing a new ischaemic stroke has been answered, due to observational design of study. Moreover, only 14 intracranial haemorrhages occurred and more than half of the study participants were treated with vitamin K antagonists, which are likely to be associated with a higher risk of intracranial haemorrhage than are direct oral anticoagulants. It suggests that the pragmatic message from this study is that although people with cerebral microbleeds are at risk of intracranial haemorrhage, they are also at high risk of ischaemic stroke, and although presence of microbleeds can be informative, counting microbleeds on an MRI is not good enough: clinicians should carefully assess the brain as a whole and go beyond the micro scope of microbleeds.